Skip to content
Wheeler Bio, Inc. logo — CMC Made for Biotechs

Wheeler Bio, Inc.

CMC Made for Biotechs

Founded 2020 United States Oklahoma City, United States 76 employees Series A Total: $80.00M Biotechnology, Health and Wellness +1

General Information

Company Name Wheeler Bio, Inc.
Founded Year 2020
Location United States Oklahoma City, United States
Employees 76
Industries Biotechnology, Health and Wellness, Life Sciences
Funding Stage Series A
Business Model B2B, SaaS
Revenue Model Service Fee, Project Based, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Wheeler Bio, Inc.. To contact Wheeler Bio, Inc., visit wheelerbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Wheeler Bio, Inc. compare?

A PDF of Wheeler Bio, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Wheeler Bio, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Wheeler Bio, Inc.

Wheeler Bio, Inc., headquartered in the United States, is a novel force in the contract development and manufacturing organization (CDMO) sector. Founded in 2020, the company operates with the slogan "CMC Made for Biotechs." It focuses on optimizing the transition from discovery to development phases for biopharmaceutical companies, specifically in the development of antibody and antibody-like therapeutics.

Wheeler Bio’s innovative Portable CMC® platform distinguishes it within the Biotechnology, Health and Wellness, and Life Sciences industries. This platform is integral to the company's strategy, designed to mitigate lifecycle challenges while boosting efficiency and promoting strategic partnerships.

In a promising step towards expansion, the company secured a $35.00M Series A investment on March 1, 2025. Key investors include Alloy Ventures, Germin8 Ventures, Echo Investment Capital, Mitsubishi, and Russell Westbrook Enterprises. This infusion of capital reflects investor confidence in Wheeler Bio’s mission and potential to impact the biopharma industry significantly.

Business keywords: Contract Development and Manufacturing Organization, Biopharmaceutical, Antibody Therapeutics, Mammalian Cell Line Development, Process Development, GLP Tox Material Supply, CGMP Clinical Supply, Portable CMC Platform, Therapeutic Innovation, Clinical Trials, Cell Line Development, Biologics, Monoclonal Antibodies, Tech Transfer, Drug Substance

Services & Products

Custom Development Services
Cell Line Development
Process Development & Optimization
Analytical Development & Qualification
Process Characterization
Technology Transfer
Toxicology Material Supply
Formulation Development

Target Customers

Biopharma Companies Drug Developers Biotech Firms Innovative Developers CMOs and CROs

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $35.00M 5
Alloy Ventures, Germin8 Ventures +3
01 Mar 2025
Series A $31.00M 8
Alloy Ventures, Floating Point Advisors +6
01 Apr 2023
Early VC Undisclosed 1
Boyd Street Ventures
01 Jan 2023
Series A Undisclosed 3
Plains Ventures, Echo Investment Capital +1
01 Oct 2022
Seed $14.00M 4
The Group Ventures, Alloy Ventures +2
01 Jan 2022
Seed Undisclosed 2
Alloy Ventures, Echo Investment Capital
01 Jul 2021

Wheeler Bio, Inc. Alternatives & Competitors

View All Alternatives
Wheeler Bio, Inc. vs

A leading CDMO delivering aseptic fill-finish services of liquid vials, lyophilized vials, syringes,...

Series C
429 employees
Biopharma, Biotechnology
Wheeler Bio, Inc. vs

GMP Contract Manufacturing Organization for Biological Therapies and Vaccines for Human Clinical Tri...

28 employees
Biotechnology, Health Care
Wheeler Bio, Inc. vs

Delivering Affordable Biopharma Solutions with a Commitment to Quality, Service, and Compliance.

Series C
Biopharma, Biotechnology

FAQ About Wheeler Bio, Inc.

CMC Made for Biotechs
Wheeler Bio, Inc. was founded in 2020.
Wheeler Bio, Inc. is headquartered in Oklahoma City, United States.
Wheeler Bio, Inc. operates in Biotechnology, Health and Wellness and Life Sciences. Its work centres on Contract Development and Manufacturing Organization, Biopharmaceutical, Antibody Therapeutics and Mammalian Cell Line Development. Its customers include Biopharma Companies, Drug Developers and Biotech Firms.
Wheeler Bio, Inc. has a B2B and SaaS business model. Its revenue comes from Service Fee, Project Based and Usage Based.
Wheeler Bio, Inc. has approximately 76 employees.
Wheeler Bio, Inc. has completed 6 funding rounds, raising a total of $80.00M. The latest funding stage is Series A.
Wheeler Bio, Inc. offers: Custom Development Services, Cell Line Development, Process Development & Optimization, Analytical Development & Qualification, Process Characterization, Technology Transfer, Toxicology Material Supply, Formulation Development, cGMP Master Cell Banking, cGMP Drug Substance Manufacturing.
Top alternatives and competitors to Wheeler Bio, Inc. include Grand River Aseptic Manufacturing, Waisman Biomanufacturing, Stelis Biopharma, BDD, 64x Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Wheeler Bio, Inc. and Grand River Aseptic Manufacturing are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Wheeler Bio, Inc., https://bouncewatch.com/company/wheeler-bio-inc, updated 25 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout